금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
WTI holds firm near $77.50 as escalating Middle East tensions threaten oil supply routes
West Texas Intermediate (WTI) oil price remains steady after registering modest gains in the previou...
US euro sale to prop up yen blindsided European Central Bank
Christine Lagarde and Scott Bessent spoke only after Washington’s historic intervention...
Lower Oil Prices Lend Support For The Gold Rally
Oil prices fell for a second week running thanks to optimism surrounding renewed U.S.-Iran diplomacy...
Home Depot (HD) Surpasses Market Returns: Some Facts Worth Knowing
Home Depot (HD) concluded the recent trading session at $348.24, signifying a +2.42% move from its prior day's close.
Intuit (INTU) Advances But Underperforms Market: Key Facts
In the closing of the recent trading day, Intuit (INTU) stood at $323.6, denoting a +1.64% move from the preceding trading day.
Macy's (M) Gains But Lags Market: What You Should Know
In the closing of the recent trading day, Macy's (M) stood at $26.21, denoting a +1% move from the preceding trading day.
Why Gold.com (GOLD) Outpaced the Stock Market Today
The latest trading day saw Gold.com (GOLD) settling at $42.9, representing a +1.83% change from its previous close.
Charlie’s Holdings names Henry Sicignano as CEO ahead of age-gated vape launch
Gold gains as lower oil prices, lackluster U.S. jobs data ease inflation fears
Stride GAAP EPS of $7.14 beats by $0.07, revenue of $2.52B beats by $10M
Pfizer Covid Pill Revenue Plunges 95%. The Stock Is Rising Anyway.
Pfizer beats earnings forecasts for the second quarter, while BioNTech’s results miss expectations due to weak Covid vaccine demand.
Par Pacific earnings surge on strong refining margins amid turnaround
Tyra Biosciences GAAP EPS of -$0.69 misses by $0.04
Novo Nordisk Raises Earnings Guidance. The Stock Sinks.
The Danish drugmaker continues to rely on the success of semaglutide, branded as Wegovy for weight loss and Ozempic for diabetes.
Stocks face their weakest seasonal stretch. Why extreme investor pessimism could limit any selling.
U.S. stocks are entering what has historically been the weakest stretch of the year, but unusually bearish investor sentiment could help limit any pullback, according to Ned Davis Research.